Heterologous prime/boost immunization in mice with DNA-ZIKV followed by MVA-ZIKV increases the magnitude of adaptive ZIKV-specific CD4+ and CD8+ T cell immune responses. Cellular immune responses are pivotal for protection against ZIKV infection [37,38]. The gene discussed is CD4; the disease is Zika virus infectious disease.